Literature DB >> 17692019

Eph/ephrin signaling as a potential therapeutic target after central nervous system injury.

J Du1, C Fu, D W Sretavan.   

Abstract

Recent work indicates that the expression of Eph and ephrin proteins is upregulated after injury in the central nervous system (CNS). Although to date, much of the interest in these protein families in the nervous system has been on their roles during development, their presence in the adult CNS at multiple time points after injury suggest that they play significant roles in key aspects of the nervous system's response to damage. Several fundamental features of Eph and ephrin biology, such as bidirectional signaling, promiscuity of ligand-receptor binding, and potential cis regulation of function, present challenges for the formulation of rational and effective Eph/ephrin based strategies for CNS axon regeneration. However, recent work that have identified specific functions for individual Ephs and ephrins in injury-induced phenomena such as axon sprouting, cellular remodeling, and scar formation has begun to tease apart their contributions and may provide a number of potential entry points for beneficial therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17692019     DOI: 10.2174/138161207781368594

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  33 in total

1.  Eph/ephrin interactions modulate muscle satellite cell motility and patterning.

Authors:  Danny A Stark; Rowan M Karvas; Ashley L Siegel; D D W Cornelison
Journal:  Development       Date:  2011-11-09       Impact factor: 6.868

Review 2.  Looking forward to EphB signaling in synapses.

Authors:  Slawomir Sloniowski; Iryna M Ethell
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

Review 3.  Targeting Eph receptors with peptides and small molecules: progress and challenges.

Authors:  Roberta Noberini; Ilaria Lamberto; Elena B Pasquale
Journal:  Semin Cell Dev Biol       Date:  2011-10-25       Impact factor: 7.727

4.  Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma.

Authors:  Christine T Fu; David Sretavan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-05       Impact factor: 4.799

5.  Crystal structure and NMR binding reveal that two small molecule antagonists target the high affinity ephrin-binding channel of the EphA4 receptor.

Authors:  Haina Qin; Jiahai Shi; Roberta Noberini; Elena B Pasquale; Jianxing Song
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

6.  Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.

Authors:  Roberta Noberini; Mitchell Koolpe; Satyamaheshwar Peddibhotla; Russell Dahl; Ying Su; Nicholas D P Cosford; Gregory P Roth; Elena B Pasquale
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

Review 7.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

Review 8.  Eph receptor signaling and ephrins.

Authors:  Erika M Lisabeth; Giulia Falivelli; Elena B Pasquale
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

Review 9.  Central nervous system regeneration inhibitors and their intracellular substrates.

Authors:  Michelle Nash; Horia Pribiag; Alyson E Fournier; Christian Jacobson
Journal:  Mol Neurobiol       Date:  2009-09-19       Impact factor: 5.590

10.  Repulsive Wnt signaling inhibits axon regeneration after CNS injury.

Authors:  Yaobo Liu; Xiaofei Wang; Chin-Chun Lu; Rachel Kerman; Oswald Steward; Xiao-Ming Xu; Yimin Zou
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.